Management of voltage-gated potassium channel antibody disorders

Neurologic Clinics

Volumn 28, Issue 4, 2010, Pages 941-959

  Merchut, Michael P ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Antibody; Limbic encephalitis; Morvan syndrome; Neuromyotonia; Potassium channel; Voltage gated

Indexed keywords

ANTIBODY; AZATHIOPRINE; CARBAMAZEPINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FOSPHENYTOIN SODIUM; GABAPENTIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PHENYTOIN; PREDNISOLONE; PREDNISONE; STEROID; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; AUTOIMMUNE DISEASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MORVAN SYNDROME; MYOKYMIA; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; ISAACS SYNDROME; LIMBIC ENCEPHALITIS; METHYLPREDNISOLONE; PLASMA EXCHANGE; POTASSIUM CHANNELS; SYRINGOMYELIA;

EID: 77956250371     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.03.024     Document Type: Review

References (51)

1. Newsom-Davis J., Buckley C., Clover L., et al. Autoimmune disorders of neuronal potassium channels. Ann N Y Acad Sci 2003, 998:202-210.
2. Kleopa K.A., Elman L.B., Lang B., et al. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 2006, 129:1570-1584.
3. Thieben M.J., Lennon V.A., Boeve B.F., et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004, 62:1177-1182.
4. Newsom-Davis J., Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): report of five cases and literature review. Brain 1993, 116:453-469.
5. Gutmann L., Tellers J.G., Vernino S. Persistent facial myokymia associated with K+ channel antibodies. Neurology 2001, 57:1707-1708.
6. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961, 24:319-325.
7. Tahmoush A.J., Alonso R.J., Tahmoush G.P., et al. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991, 41:1021-1024.
8. Shillito P., Molenaar P.C., Vincent A., et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995, 38:714-722.
9. Hart I.K., Maddison P., Newsom-Davis J., et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002, 125:1887-1895.
10. Vernino S., Lennon V.A. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002, 26:702-707.
11. Bady B., Chauplannaz G., Vial C., et al. Autoimmune aetiology for acquired neuromyotonia. Lancet 1991, 338:1330.
12. Riche G., Trouillas P., Bady B. Improvement of Isaacs' syndrome after treatment with azathioprine. J Neurol Neurosurg Psychiatry 1995, 59:448.
13. Heidenreich F., Vincent A. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia and peripheral neuropathy. Neurology 1998, 50:1483-1485.
14. Bednarik J., Kadanka Z. Volitional and stimulation induced neuromyotonic discharges: unusual electrophysiological pattern in acquired neuromyotonia. J Neurol Neurosurg Psychiatry 2001, 70:406-425.
15. Oh S., Alapati A., Claussen G.C., et al. Myokymia, neuromyotonia, dermatomyositis and voltage-gated K+ channel antibodies. Muscle Nerve 2003, 27:757-760.
16. Takahashi H., Mori M., Sekiguchi Y., et al. Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis. J Neurol Sci 2008, 275:185-187.
17. Wallis W.E., Poznak A.V., Plum F. Generalized muscle stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol 1970, 22:430-439.
18. Gonzalez G., Barros G., Russi M.E., et al. Acquired neuromyotonia in childhood: case report and review. Pediatr Neurol 2008, 38(1):61-63.
19. Dhand U.K. Isaacs' syndrome: clinical and electrophysiological response to gabapentin. Muscle Nerve 2006, 34:646-650.
20. Vernino S., Auger R.G., Emslie-Smith A.M., et al. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999, 53:1233-1239.
21. Buckley C., Oger J., Clover L., et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001, 50:73-78.
22. Gultekin S.H., Rosenfeld M.R., Voltz R., et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000, 123:1481-1494.
23. Yu Z., Kryzer T.J., Griesmann G.E., et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154.
24. Lawn N.D., Westmoreland B., Kiely M.J., et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 2003, 78:1363-1368.
25. Ances B.M., Vitaliani R., Taylor R.A., et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005, 128:1764-1777.
26. Bataller L., Kleopa K.A., Wu G.F., et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 2007, 78:381-385.
27. Pozo-Rosich P., Clover L., Saiz A., et al. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003, 54:530-533.
28. Vincent A., Buckley C., Schott J., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
29. Hiraga A., Kuwabara S., Hayakawa S., et al. Voltage-gated potassium channel antibody-associated encephalitis with basal ganglia lesions. Neurology 2006, 66(1):1780-1781.
30. Parthasarathi U.D., Harrower T., Tempest M., et al. Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Br J Psychiatry 2006, 189:182-183.
31. Ohshita T., Kawakami H., Maruyama H., et al. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma. J Neurol Sci 2006, 250:167-169.
32. Harrower T., Foltynie T., Kartsounis L., et al. A case of voltage-gated potassium channel antibody-related limbic encephalitis. Nat Clin Pract Neurol 2006, 2(6):339-343.
33. McKeon A., Marnane M., O'Connell M., et al. Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Arch Neurol 2007, 64(10):1528-1530.
34. Jacob S., Irani S.R., Rajabally Y.A., et al. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:202-204.
35. Rueff L., Graber J.J., Bernbaum J., et al. Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations. Rev Neurol Dis 2008, 5(2):65-72.
36. Sekiguchi Y., Takahashi H., Mori M., et al. Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction. J Neurol Sci 2008, 269:176-179.
37. Jarius S., Hoffman L., Clover L., et al. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008, 268(1-2):74-77.
38. Morvan A. De la chorée fibrillaire. Gaz Hebd Med Chir 1890, 27:173-200. [in French].
39. Lee E.K., Maselli R.A., Ellis W.G., et al. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 1998, 65:857-862.
40. Liguori R., Vincent A., Clover L., et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001, 124(12):2417-2426.
41. Mitsumoto H., Wilbourn A.J. Generalized myokymia and gold therapy. Arch Neurol 1982, 39:449-450.
42. Madrid A., Gil-Peralta A., Gil-Néciga E., et al. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol 1996, 243:350-353.
43. Maselli R.A., Agius M., Lee E.K., et al. Morvan's fibrillary chorea: electrodiagnostic and in vitro microelectrode findings. Ann N Y Acad Sci 1998, 841:497-500.
44. Agius M.A., Zhu S., Lee E.K., et al. Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea. Ann N Y Acad Sci 1998, 841:522-524.
45. Barber P.A., Anderson N.E., Vincent A. Morvan's syndrome associated with voltage-gated K channel antibodies. Neurology 2000, 54(3):771-772.
46. Cottrell D.A., Blackmore K.J., Fawcett P.R., et al. Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry 2004, 75:1504-1505.
47. Josephs K.A., Silber M.H., Fealey R.D., et al. Neurophysiologic studies in Morvan's syndrome. J Clin Neurophysiol 2004, 21:440-445.
48. Diaz-Manera J., Rojas-Garcia R., Gallardo E., et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007, 3(7):405-410.
49. Bajaj B.K., Shrestha S. An interesting case report of Morvan's syndrome from the Indian subcontinent. Neurol India 2007, 55(1):67-69.
50. Loescher W.N., Wanschitz J., Reiners K., et al. Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve 2004, 30:157-163.
51. Deymeer F., Akca S., Kocaman G., et al. Fasciculations, autonomic symptoms and limbic encephalitis: a thymoma-associated Morvan's-like syndrome. Eur Neurol 2005, 54:235-237.